Laboratorios Casasco is a pharmaceutical manufacturing company headquartered in Buenos Aires, Argentina. It was founded in 1876, making it one of the country’s oldest pharmaceutical companies. Our mission is to advance global health and well-being by developing pharmaceutical products of the highest quality, grounded in scientific excellence and ethical integrity. Our portfolio includes cardiovascular health, Urology, Neurology and psychiatry, Immunology, Endocrinology (e.g., diabetes), Anti-infectives, Gastrointestinal treatments, Women’s health, and preventive medicine. Born in the 19th century, walked along the 20th century, and entered the 21st century as an enduring Argentine endeavor through the centuries.
K-BIO Materials, Parts and Equipment Special Pavilion Hosted by KEIT
Korea Planning & Evaluation Institute of Industrial Technology (KEIT) specializes in the planning, evaluation, and management of national R&D projects in industrial technology under the Ministry of Trade, Industry and Energy (MOTIE). Our Materials, Parts and Equipment (MPE) Pavilion includes the following companies: ① JEIO TECH CO., LTD. Reliable manufacturer for biology, chemistry, medicine, and pharmacology | labcompanionshop.com ② MICRODIGITAL CO., LTD. Biomedical and bioprocess innovation | md-best.com/en ③ CELLSAFE CO., LTD. Mycoplasma testing, replication competent virus, host cell DNA | cells-safe.com ④ DUKSAN PURE CHEMICALS GMP-compliant high-purity solvents | duksan.kr ⑤ ECONITY CO., LTD. Membrane manufacturing for advanced applications | econity.com ⑥ AMICOGEN INC. CDMO for cell culture media and chromatography resins | amicogen.com/en
Jeonnam Bio Foundation
The Jeonnam Bio Foundation(jBF) is a prominent entity in Korea, noted for its high productivity and competitiveness within the bioindustry sector. The jBF is engaged in a variety of activities aimed at enhancing the bioindustry, including the development of functional foods, vaccines, pharmaceuticals, natural products, and products for medicine and cosmetics. They leverage Jeollanamdo’s rich natural resources for these developments, positioning bio-industries as strategic future industries for the region. Jeollanamdo is also recognized for its significant contribution to agriculture and fisheries, producing 19% of domestic agricultural products and 43% of domestic fishery products in Korea. The region is a leader in eco-friendly agricultural production, with 60% of its agricultural land using no pesticides, which underscores its commitment to sustainable and environmentally friendly practices. Furthermore, the Jeonnam Bio Foundation supports vaccine and pharmaceutical start-ups in collaboration with local institutions, such as the Hwasun Vaccine Industry Special District and Chonnam National University Hwasun Hospital, showcasing a strong emphasis on research and development (R&D) and innovation within the bioindustry sector. | Jeonnam Bio Foundation (JBF) *Organization Overview The Jeonnam Bio Foundation (JBF) is a public institution established by the Jeollanam-do Provincial Government to serve as a cornerstone for the growth and innovation of South Korea’s bioindustry. Strategically located within Jeonnam’s specialized bio-clusters, JBF plays a vital role in fostering industrial development, promoting technology commercialization, and supporting global market entry for biotechnology-driven enterprises. *Mission and Vision JBF is dedicated to creating a dynamic ecosystem for the bioindustry by connecting research with commercialization, supporting startups and SMEs, and advancing regional and global collaboration. The foundation envisions establishing Jeonnam as a global leader in sustainable and innovative biotechnology. * Core Functions 1) Enterprise Support – Business incubation and consulting for bioindustry startups and small to medium enterprises – Operation and rental of pilot production facilities and lab infrastructure – Regulatory and certification support (HACCP, GMP, ISO, etc.) 2) Technology Transfer & Commercialization – Promotion of joint R&D and transfer of technologies from academic and public institutions to industry – IP management and licensing services – Bridging academia and industry through innovation pipelines 3) Global Market Expansion – Assistance with international exhibitions, overseas buyer matching, and export consulting – Support for product registration and certification in global markets – Development of global partnerships and technology licensing agreements 4) Human Resource Development – Technical training and workforce development programs in bioprocessing and quality systems – Academic collaboration with universities and research institutions – Industry-focused job training and professional education *Strategic Role Located in Jeonnam’s national bioindustrial complexes, JBF offers integrated support combining research, testing, production, and commercialization. This strategic positioning makes JBF a crucial platform for domestic and global companies seeking to scale their bio-related technologies. *Notable Achievements – Successful incubation of numerous regional bioenterprises – Technology transfer and licensing to commercial partners – Hosting of international conferences and trade delegation events – Recognition for excellence in regional economic development and innovation
IZB – Innovation and Start-up Center Biotechnology
Hotspot for Life Sciences The Innovation and Start-up Center Biotechnology (IZB) with sites in Planegg-Martinsried and Freising-Weihenstephan near Munich, is one of the leading biotechnology centers in Europe. The company Fördergesellschaft IZB mbH, founded in 1995, operates IZB. IZB hosts over 40 biotech companies with more than 700 employees across a 26,000 m² area. At the main site in Planegg-Martinsried, spanning 23,000 m², resident start-ups primarily focus on medical biotechnology. IZB in Freising provides ideal conditions for founders in the life sciences sector. Outstanding infrastructure IZB offers young companies a superior environment and infrastructure for realizing their product and service ideas. Crucial for successful growth are S1 laboratories and office spaces that flexibly adapt to the companies‘ needs. Additionally, IZB provides excellent infrastructure. At the Martinsried location, start-ups have access to modern conference rooms, a design hotel, the restaurants „The Bowl“ and „Seven and More“, as well as the Bio Kids kindergarten. A strong network A vital success factor for IZB start-ups is the close proximity of both locations to cutting-edge research. On the Weihenstephan Campus, you’ll find the TUM school of Life Sciences of the Technical University of Munich, as well as the University of Applied Sciences Weihenstephan-Triesdorf. Adjacent to the IZB on the Martinsried/Großhadern campus, you‘ll find, among others, two Max Planck Institutes, faculties, and facilities of LMU, as well as the University Hospital of Munich-Großhadern. IZB fosters this strong network with an array of event formats like the IZBrunch and the Munich Life Science Pitch Day at the G2B Faculty Club, establishing itself as a key meeting point in the industry.
INDIA PAVILION
Association of Biotechnology Led Enterprises – ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech, Bio-pharma, Industrial biotech, Bioinformatics, Investment banks and Venture Capital firms, leading Research and Academic Institutes and Law Firms and Equipment Suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector. | Association of Biotechnology Led Enterprises – ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech, Bio-pharma, Industrial biotech, Bioinformatics, Investment banks and Venture Capital firms, leading Research and Academic Institutes and Law Firms and Equipment Suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector. ABLE showcases India’s biotech sector through events like BioEconomy Conclave, Voice for BT public speaking contest, brings out India BioEconomy Report, BioEconomy Reports for states like Karnataka and sets up the India Pavilion at the BIO International event in the USA annually. ABLE Council of Presidents, that comprises of all past presidents of the organization, provides valuable inputs for the growth of the Biotech business ecosystem, leveraging their multi-sectoral expertise. ABLE thus catalyses a symbiotic interface between the industry, the government, academic and research institutes and domestic and international investors. | Association of Biotechnology Led Enterprises – ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech, Bio-pharma, Industrial biotech, Bioinformatics, Investment banks and Venture Capital firms, leading Research and Academic Institutes and Law Firms and Equipment Suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector. ABLE showcases India’s biotech sector through events like BioEconomy Conclave, Voice for BT public speaking contest, brings out India BioEconomy Report, BioEconomy Reports for states like Karnataka and sets up the India Pavilion at the BIO International event in the USA annually. | Stop by the booth to learn more! | Government of India/Ministry of Ports, Shipping and Waterways has established the Cruise Bharat Mission Secretariat under the aegis of the Indian Ports Association. Cruise Bharat Mission focuses on three cruise segments- Ocean & Harbour Cruise, River & Inland Cruise and Island Cruise.
Hong Kong Baptist University: Institute for Innovation, Translation and Policy Research
Hong Kong Baptist College was founded by the Baptist Convention of Hong Kong in 1956. In 1983, it became a fully funded public tertiary institution, and the College gained university status just over a decade later. It was renamed Hong Kong Baptist University (HKBU) in 1994. The Institute for Innovation, Translation and Policy Research (ITPR) within HKBU serves to drive innovations, research and development, technology translation, and applications to enable HKBU to respond to emerging challenges and opportunities globally, nationally, as well as those under the aegis of the Hong Kong SAR Government’s top policy priority on innovation and technology development. ITPR strives to bridge the gap in technology readiness between academic innovation and industry applications. ITPR also helps to advance HKBU’s innovation capacity and enhance up- to mid-stream research and technology development capabilities through establishing collaborative platforms, engaging stakeholders, facilitating high-impact innovation and multidisciplinary R&D.
Finao Biotech
FINAO Biotech is a pharmaceutical company specializing in biotechnology, based in Rio de Janeiro, Brazil with global reach. Our goal is to serve, to improve the quality of life of our customers through a range of innovative products based on sustainable development, production, distribution and commercialization of medicines, innovative medical devices, cosmetics, food supplements and veterinary. At FINAO Biotech we care about society and the environment. Our innovative medical products, highly efficient, reflect our concerns and represent our strength in doing more and better, combining technology with the environment and society. Words like efficiency and sustainability have accompanied our company. The search for the best pharmaceutical development solutions has made FINAO Biotech’s portfolio broader, with a range of innovative products.
CNABIOTECH Co., Ltd
CNABIOTECH CO.,LTD. is a company that pursues health, youth, and pleasure. Under the corporation philosophy of “being one with customers”, we strive to improve the quality of life of customers by providing customers with satisfaction and trust based on the new values found by taking one stop forward in finding the products and services that customers pursue. We, CNABIOTECH CO.,LTD. believe that the best quality is the only way for us to grow as a leading biotechnology company. Following the development of the collagen peptides that forms the foundation of our company, we continue our R&D investments. As a result, based on our advanced technology in the field of biological engineering such as (e.g. highfunction bioactive substances relating to skin), we will achieve sustainable growth in the high-value industry of the 21st century. Furthermore, we will strive to intensely develop biological industrial materials as our winning project by establishing an industry-university joint development system with local universities and related institutions, and thereby will grow into a world’s leading bio venture company producing world-class achievements.
Brazilian Center for Research – CNPEM
CNPEM is a sophisticated and ebullient environment for research and development that is the only one of its kind in Brazil and found in only a few scientific centers in the world. The Center private, non-profit organization overseen by the Ministry of Science, Technology, and Innovation (MCTI). The Center is home to Sirius, the most complex project in Brazilian science and one of the world’s most advanced synchrotron light sources. CNPEM comprises highly specialized multi-thematic teams, globally competitive lab infrastructure that is open to the scientific community, strategic lines of research, innovative projects in partnerships with the productive sector, and training programs for researchers and students. CNPEM is an environment driven by research into solutions that impact the areas of health, energy and renewable materials, agro environmental and engineering. | The Brazilian Center for Research in Energy and Materials (CNPEM) is home to a state-of-the-art, multi-user and multidisciplinary scientific environment. A social organization overseen by the Ministry of Science, Technology and Innovation, CNPEM powers Brazil’s science with cutting-edge labs like Sirius, tackling global challenges in health, renewable materials, energy & sustainability.